8 Results for "

Dual COX-2/15-LOX inhibitors

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "Dual COX-2/15-LOX inhibitors" in MCE Product Catalog:

Cat. No.: HY-155159
CAS No.: 3052736-49-6
Target:  

COX Lipoxygenase

Research Areas:  

Inflammation/Immunology

COX-2/15-LOX-IN-2 is a potent dual COX-2 and 15-LOX inhibitor with IC50 values of 0.065 μM and 1.86 μM, respectively. COX-2/15-LOX-IN-2 has potent antioxidant activity .
loading...
    loading...
Cat. No.: HY-168340
Target:  

COX Lipoxygenase

Research Areas:  

Inflammation/Immunology

COX-2/15-LOX-IN-6 (Compound 5l) is the dual inhibitor for COX-2 and 15-LOX, with IC50 of 0.201 μM and 11.723 μM. COX-2/15-LOX-IN-6 inhibits the expression of PGE, TNF-α, IL-6 and iNOS in serum, and exhibits anti-inflammatory effect in Carrageenan (HY-125474)-induced rats edema model .
loading...
    loading...
Cat. No.: HY-179021
CAS No.: 1860810-23-6
Target:  

COX Lipoxygenase

Research Areas:  

Cancer

COX-2/15-LOX-IN-7 is a potent, selective and orally active dual inhibitor of COX-2 and 15-LOX with IC50 values of 0.022 and 1.19 μM. COX-2/15-LOX-IN-7 also inhibits COX-1 with an IC50 value of 28.081μM. COX-2/15-LOX-IN-7 has low cytotoxicity against human colorectal cancer HT-29 and HCT116 cell lines (IC50 >100 μM for both). COX-2/15-LOX-IN-7 exhibits non-ulcerogenic performance. COX-2/15-LOX-IN-7 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-114796
CAS No.: 43230-43-9
Target:  

Lipoxygenase

Research Areas:  

Inflammation/Immunology

tHGA is a compound with anti-inflammatory activity and has the activity to inhibit soybean 15-LOX. tHGA showed significant inhibitory effects in experiments on human leukocytes, with an IC50 value of 0.42 μM, which is close to the effect of commonly used standard NDGA. tHGA concentration-dependently inhibits the synthesis of 5-LOX products, especially the cysteine leukotriene LTC(4), with an IC50 value of 1.80 μM. and showed no cytotoxicity. The anti-inflammatory effects of tHGA do not appear to be through redox or metal chelation mechanisms, as the compound was negative in these bioactivity tests. tHGA works through a dual LOX/COX inhibition mechanism and has higher selectivity for 5-LOX and COX-2, with an IC50 value of 0.40 μM .
loading...
    loading...
Cat. No.: HY-N18218
CAS No.: 219917-70-1
Speranskoside is a dual COX-2/15-LOX inhibitor with a COX-2 IC50 of 2.62 μg/mL and a 15-LOX IC50 of 5.51 μg/mL. Speranskoside can be used for the research of gastric ulcers .
loading...
    loading...
Cat. No.: HY-163355
CAS No.: 443790-30-5
Target:  

COX Lipoxygenase NF-κB

Research Areas:  

Inflammation/Immunology

COX-2/15-LOX-IN-5 (Compound 4f) is a dual inhibitor of COX-2/15-LOX. COX-2/15-LOX-IN-5 attenuates increased NF-κB activation in RAW 264.7 macrophages mediated by lipopolysaccharide (HY-D1056). COX-2/15-LOX-IN-5 has anti-inflammatory and antioxidant activities .
loading...
    loading...
Cat. No.: HY-155160
CAS No.: 3052736-47-4
Target:  

Lipoxygenase COX

Research Areas:  

Inflammation/Immunology

COX-2/15-LOX-IN-3 (compound 5k) is a dual inhibitor of COX-2/15-LOX with IC50s of 0.075 μM and 1.97 μM, respectively. COX-2/15-LOX-IN-3 can inhibit LPS-induced cell production of promoting cytokines (IL-6, ROS, and NO), with specific anti-inflammatory activity .
loading...
    loading...
Cat. No.: HY-155161
CAS No.: 3052736-45-2
Target:  

Lipoxygenase COX

Research Areas:  

Inflammation/Immunology

COX-2/15-LOX-IN-4 (compound 5i) is a dual inhibitor of COX-2/15-LOX with IC50s of 0.075 μM and 1.97 μM, respectively. COX-2/15-LOX-IN-4 can inhibit LPS-induced cell production of promoting cytokines (IL-6, ROS) with specific anti-inflammatory activity .
loading...
    loading...